Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04752059
Title Phase II Study of T-DX in HER2-positive Breast Cancer Brain Metastases (TUXEDO-1)
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Medical University of Vienna

Her2-receptor positive breast cancer


Trastuzumab deruxtecan

Age Groups: adult
Covered Countries AUT

No variant requirements are available.